Hypomodification of transfer RNA in cancer with respect to queuosine

Chandramani Pathak1, Yogesh K Jaiswal, Manjula Vinayak

  • 1School of Studies In Biochemistry, Jiwaji University, Gwalior, India.

RNA Biology
|November 23, 2006
PubMed

Insights

Queuosine modification in transfer RNA (tRNA) is often incomplete in cancerous cells, correlating with reduced transfer RNA guanine transglycosylase (TGTase) activity. Supplementing with queuine can restore tRNA modification, suggesting a therapeutic target for malignancy.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Research

Background:

  • Queuosine is a unique modified nucleoside found in specific transfer RNAs (tRNAs), essential for their function.
  • Transfer RNA guanine transglycosylase (TGTase) is the enzyme responsible for queuosine modification.
  • Hypomodification of tRNA with queuosine is observed in actively dividing cells and is linked to cancer.

Purpose of the Study:

  • To investigate the role of queuosine modification and TGTase activity in cancer.
  • To compare tRNA modification and TGTase activity in normal, cancerous, and queuine-treated cancerous mouse liver.
  • To explore the potential of exogenous queuine as a therapeutic intervention.

Main Methods:

  • Comparison of queuosine modification levels in tRNA from normal, Dalton's lymphoma ascites transplanted (DLAT) cancerous, and queuine-treated DLAT cancerous mouse liver.
  • Assay of TGTase enzyme activity in the same experimental groups.
  • Investigation of the effects of activators (NaPP, ATP) and inhibitor (7mG) on TGTase activity.

Main Results:

  • Cancerous mouse liver exhibited hypomodified tRNA with significantly reduced TGTase activity compared to normal controls.
  • Exogenous administration of queuine improved queuosine modification in the tRNA of cancerous mice.
  • TGTase activity was enhanced by NaPP and ATP, while 7mG inhibited the enzyme in both normal and cancerous samples.

Conclusions:

  • Reduced TGTase activity contributes to tRNA hypomodification in cancer.
  • Restoration of queuosine modification via exogenous queuine shows promise for cancer therapy.
  • TGTase activity can be modulated by specific activators and inhibitors, offering potential therapeutic targets.

Related Concept Videos

Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...